can you take semaglutide with thyroid nodules and Hypothyroidism: Safety Guide Just a word of caution

What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months

Its often used for people managing chronic fatigue, inflammation, or neuropathy

Semaglutide reduces severity of common liver disease in people with HIV

Ipamorelin and CJC-1295 are not interchangeable

But the oral Wegovy pill was approved in late 2025 and pharmaceutical companies are reportedly working on more pills that will likely give patients more options in the future.